MedTrace Logo

Atrial Fibrillation Ablation Registry

NCT03075930 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2020-02-20

No results posted yet for this study

Summary

This is a single centre prospective data registry. In this study atrial conduction characteristics of extended surface Electrocardiograms (esECG), biomarkers and genetic analysis will be performed before ablation, before discharge and 3 months after catheter ablation of atrial fibrillation (AF) and compared to routine clinical follow-up data.

The objective of this registry is to establish a data registry of patients undergoing ablation of AF. Supplementary to the routine clinical diagnostic an esECG and an analysis of biomarkers will be performed and compared to clinical and outcome data.

Conditions

  • Atrial Fibrillation (Paroxysmal)
  • Atrial Fibrillation Recurrent
  • Atrial Fibrillation Common Gene Variants

Interventions

DEVICE

Extended Electrocardiogram

ECG with 3 additional leads and a 5 minute recording

DEVICE

Body surface potential map

ECG with 184 leads and a 5 minute recording

Sponsors & Collaborators

  • RWTH Aachen University

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Laurent Pison, Physician · Maastricht University

  • Ulrich Schotten, Physician · Maastricht University

  • Matthias D Zink, Physician · Maastricht University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-12
Primary Completion
2022-01-31
Completion
2023-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075930 on ClinicalTrials.gov